The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial PD-L1/PD-1 blockade avelumab with chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer: The Ave-Rec trial.
 
Michael Michael
Consulting or Advisory Role - Ipsen; Merck
 
Rachel Wong
No Relationships to Disclose
 
Sanjeev Singh Gill
No Relationships to Disclose
 
David Goldstein
Stock and Other Ownership Interests - Sirtex Medical
Consulting or Advisory Role - sun biopharma
Research Funding - Amgen (Inst); Bayer (Inst); Celgene (Inst); pfizer (Inst)
 
Sam Ngan
No Relationships to Disclose
 
Alexander Graham Heriot
No Relationships to Disclose
 
Emma Link
Patents, Royalties, Other Intellectual Property - Emma is an innovator: the discovery of her DPhil has been the subject of patent applications in the USA, UK, Europe, China, and Japan. The US rights to the patent were granted to Boston Heart Diagnostics which optimised the test on their technology platfo
 
Maria Farrell
No Relationships to Disclose
 
Paul J Neeson
Research Funding - Allergan; Bristol-Myers Squibb; Compugen; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Robert George Ramsay
Honoraria - Merck Serono
Research Funding - Fisher and Paykel; Merck Serono; Targovax
Travel, Accommodations, Expenses - Fisher and Paykel
 
Kasmira Wilson
No Relationships to Disclose
 
Catherine Mitchell
Stock and Other Ownership Interests - CSL Limited; Ramsay Health
 
Jeanne Tie
Honoraria - Amgen; Merck Serono; Roche; Sirtex Medical
Consulting or Advisory Role - Amgen; Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Nick Pavlakis
No Relationships to Disclose
 
John Raymond Zalcberg
Stock and Other Ownership Interests - Aimmune; Alnylam; Biomarin; Bluebird Bio; Cochlear; CSL Limited; Dova Pharmaceuticals; GW Pharmaceuticals; Juno Therapeutics; Kiadis Pharma; Kite, a Gilead company; Sage Therapeutics; TherapeuticsMD; Vertex
Honoraria - Gilead Sciences; Halozyme; Merck Serono; pfizer; Specialised Therapeutics; Targovax
Consulting or Advisory Role - Halozyme; Lipotek; Merck Serono; Merck Sharp & Dohme; Pfizer; Sirtex Medical; Targovax
Research Funding - AstraZeneca (Inst); Baxalta/Shire (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono (Inst); Pfizer (Inst); Roche (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Merck Serono; Merck Sharp & Dohme
 
Eva Segelov
Consulting or Advisory Role - Ipsen; MSD
Research Funding - Clinical Genomics (Inst); Cynata Therapeutics (Inst)
Travel, Accommodations, Expenses - Amgen; Roche